Evidence map›Paper›PMID 22069761›Full record

ReviewToxins2011

Passive and active vaccination strategies to prevent ricin poisoning.

Seth H Pincus, Joan E Smallshaw, Kejing Song, Jody Berry, Ellen S Vitetta

Open access · goldAbstract readReview
In one paragraph

Review in Toxins, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Article
  3. The Search for Antidotes Against Ricin.Mini reviews in medicinal chemistry · 2024
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Particulate delivery systems for vaccination against bioterrorism agents and emerging infectious pathogens.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2017
    Review
  13. Ricin Toxicity: Clinical and Molecular Aspects.Reports of biochemistry & molecular biology · 2016
    Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Seth H PincusChildren's Hospital and LSU Health Sciences Center, New Orleans, LA 70118, USA. spincus@chnola-research.orgs
Joan E Smallshaw
Kejing Song
Jody Berry
Ellen S Vitetta
Children's Hospital of New Orleans · USThe University of Texas Southwestern Medical Center · US

Funding

WRCE Nonhuman Primate CoreU54AI057156 · NIAID · UNIVERSITY OF TEXAS MEDICAL BR GALVESTON · PI WALKER, DAVID H · 2003 to 2013
$102.6M
Mechanisms of Antibody-Mediated Toxin NeutralizationR01AI059376 · NIAID · LOUISIANA STATE UNIV HSC NEW ORLEANS · PI PINCUS, SETH H. · 2004 to 2008
$1.9M
NIAID NIH HHS R01 AI059376NIAID NIH HHS U54 AI057156
6 · The paper itself

Abstract

Ricin toxin (RT) is derived from castor beans, produced by the plant Ricinus communis. RT and its toxic A chain (RTA) have been used therapeutically to arm ligands that target disease-causing cells. In most cases these ligands are cell-binding monoclonal antibodies (MAbs). These ligand-toxin conjugates or immunotoxins (ITs) have shown success in clinical trials [1]. Ricin is also of concern in biodefense and has been classified by the CDC as a Class B biothreat. Virtually all reports of RT poisoning have been due to ingestion of castor beans, since they grow abundantly throughout the world and are readily available. RT is easily purified and stable, and is not difficult to weaponize. RT must be considered during any "white powder" incident and there have been documented cases of its use in espionage [2,3]. The clinical syndrome resulting from ricin intoxication is dependent upon the route of exposure. Countermeasures to prevent ricin poisoning are being developed and their use will depend upon whether military or civilian populations are at risk of exposure. In this review we will discuss ricin toxin, its cellular mode of action, the clinical syndromes that occur following exposure and the development of pre- and post-exposure approaches to prevent of intoxication.

Indexed as

AnimalsChemical Warfare AgentsHumansPoisoningRicinVaccinationChemical Warfare AgentsRicinantibodiesbiothreatricinvaccines

Identifiers

PMID22069761
PMCPMC3202875
OpenAlexW2050301496

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.